Search

everythinglearnresearchcommunity

for

Search:↓

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Some breast cancer chemotherapy can cause permanent hair loss.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Some patients' hair grew back black and white after chemotherapy.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Oral minoxidil may effectively treat hair loss from chemotherapy.

Dutasteride may help shrink prostate cancer tumors.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Vitamin C was found to effectively treat prickly heat in children.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

PLD is an effective and safer alternative for treating breast cancer.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.